study to compaire the role of Ayurvedic and modern medicine in CKD.
Phase 3
- Conditions
- Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)
- Registration Number
- CTRI/2022/07/043780
- Lead Sponsor
- MGACRC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.age 20years to 70 years.
2. diagnosed patient of CKD (BEST on eGFR,and Albuminuria clinically stable patient of stage 1to3 will be included
stage 1- GFR >90.
stage2- gfr between 60 to 89
stage 3-3a.eGFR 45TO <60
3b.eGFR 30 TO <45
Exclusion Criteria
1.post renal transplant.
2. known case of HIV patients or subjects or subjects on immune suppressive drug.
3. pregnant and lactating femeles
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To access the efficacy of bruhatyadi kwath on symptoms,e GFR,and Albuminuria in Chronic Kidney Disease. <br/ ><br>2.To access the efficacy of bruhtyadi kwath with furosemide on symptomes, eGFR and albuminuria chronic Kidney disease. <br/ ><br>3.To access the efficacy of furosemide on symptoms, eGFR And albuminuria in chronic kidney disease <br/ ><br>4.To compare the effect of above therapy in various stages of chronic kidney disease.Timepoint: Assessment will be reported on baseline, 30th day, 60 th day,&90th day on the basis of subjective & objective parameters
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI